Details for Patent: 8,314,156
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,314,156 protect, and when does it expire?
Patent 8,314,156 protects ABRAXANE and is included in one NDA.
Protection for ABRAXANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-seven patent family members in twenty-one countries.
Summary for Patent: 8,314,156
|Title:||Compositions and methods of delivery of pharmacological agents|
|Abstract:||The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. He human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The inventor also provides methods for reducing on or more side effects of administration of the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell.|
|Inventor(s):||Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA), Trieu; Vuong (Calabasas, CA)|
|Assignee:||Abraxis BioScience, LLC (Los Angeles, CA)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 8,314,156|
Patent Claim Types:|
see list of patent claims
Drugs Protected by US Patent 8,314,156
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use||Submissiondate|
|Bristol-myers||ABRAXANE||paclitaxel||POWDER;INTRAVENOUS||021660-001||Jan 7, 2005||RX||Yes||Yes||See Plans and Pricing||See Plans and Pricing||Y||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Patented / Exclusive Use||>Submissiondate|
International Family Members for US Patent 8,314,156
|Country||Patent Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Australia||2003299590||See Plans and Pricing|
|Brazil||0317134||See Plans and Pricing|
|Canada||2509365||See Plans and Pricing|
|China||102343094||See Plans and Pricing|
|>Country||>Patent Number||>Estimated Expiration||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration|